David WangEngineering A Cure for DiabetesA.B. Lucas S.S. This project investigated the feasibility of the cost-effective production of a human regulatory cytokine, IL-13 in transgenic plants for the treatment of Type 1 diabetes (T1D). Transgenic plants producing large amounts of IL-13 were generated. In vitro bioassays demonstrated that the plant-derived IL-13 effectively induced the proliferation … Continue reading David Wang